Pediatrix Medical Group (NYSE:MD) Shares Gap Up - Should You Buy?

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $12.44, but opened at $13.18. Pediatrix Medical Group shares last traded at $12.98, with a volume of 35,468 shares traded.

Analyst Ratings Changes

Several research analysts have commented on the company. Deutsche Bank Aktiengesellschaft lifted their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Truist Financial lowered their price objective on Pediatrix Medical Group from $16.00 to $15.00 and set a "hold" rating on the stock in a research report on Monday, January 6th. UBS Group boosted their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a "neutral" rating in a research report on Tuesday, November 5th. Jefferies Financial Group boosted their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Finally, Mizuho boosted their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group has an average rating of "Hold" and an average price target of $16.25.

Pediatrix Medical Group Price Performance

The company has a market capitalization of $1.14 billion, a P/E ratio of -4.35, a P/E/G ratio of 2.00 and a beta of 1.58. The company has a 50 day moving average price of $14.30 and a 200 day moving average price of $11.62. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The company had revenue of $511.20 million during the quarter, compared to analysts' expectations of $498.87 million. During the same quarter in the previous year, the firm earned $0.29 EPS. Pediatrix Medical Group's revenue was up .9% on a year-over-year basis. On average, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

Insider Transactions at Pediatrix Medical Group

In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the firm's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $16.00, for a total transaction of $129,728.00. Following the sale, the executive vice president now owns 135,810 shares in the company, valued at $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Mark S. Ordan sold 27,600 shares of the firm's stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the transaction, the director now directly owns 138,683 shares in the company, valued at $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds have recently added to or reduced their stakes in MD. Quest Partners LLC raised its position in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares in the last quarter. Quarry LP boosted its stake in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Pediatrix Medical Group during the second quarter worth $72,000. CWM LLC lifted its position in Pediatrix Medical Group by 134.0% during the third quarter. CWM LLC now owns 6,427 shares of the company's stock valued at $74,000 after purchasing an additional 3,681 shares during the period. Finally, Vanguard Personalized Indexing Management LLC acquired a new position in shares of Pediatrix Medical Group in the second quarter worth about $81,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.